The power of stories over statistics

Neonatal jaundice and infant safety on aeroplanes provide two lessons on the power of narrative, rather than statistical evidence, in determining practice I've always been more comfortable with numbers than with narrative, demanding data rather than accepting anecdotes. Recently, however, as a result of research in two unrelated areas—neonatal jaundice and infant safety on aeroplanes—I've been increasingly impressed with the power of stories over statistics. So I've decided to branch out from my usual publication format and tell a few stories of my own. The jaundice story is one of me trying to treat jaundice in newborns according to the best evidence. Ironically, the more of an expert on the evidence I have become, the more difficulty I have practising according to that evidence. This is because becoming a “jaundice expert” means becoming familiar with rare but tragic stories of children with kernicterus. These stories are so powerful that it is hard to keep them from trumping other evidence in determining practice. My neonatal jaundice story starts in the early 1980s, when I was a resident in paediatrics at the University of California, San Francisco. At that time, we treated babies with phototherapy when they had bilirubin concentrations above 14 mg/dl (239 μmol/l), and did exchange transfusions for concentrations above 20 mg/dl (342 μmol/l). Unfortunately, the early 1980s was not a good time to be transfusing blood in San Francisco. Although we did not know it then, the blood supply was contaminated with HIV. We also did not know that most of these exchange transfusions were unnecessary. ![][1] There's a story behind the “kinder, gentler” treatment thresholds for jaundice in newborns Credit: JAMES STEVENSON/SPL In 1983, in an article entitled “Bilirubin 20mg/dL = vigintiphobia,” Watchko and Oski questioned the “fear of twenty” that led to exchange transfusions for jaundice in healthy … [1]: /embed/graphic-1.gif

[1]  Robyn M. Dawes,et al.  A message from psychologists to economists : mere predictability doesn ’ t matter like it should ( without a good story appended to it ) , 1999 .

[2]  C. Margolis,et al.  Practice parameter: management of hyperbilirubinemia in the healthy term newborn. American Academy of Pediatrics. Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. , 1994, Pediatrics.

[3]  Z. Ergaz,et al.  Effect of publication of the “Practice Parameter for the Management of Hyperbilirubinemia” on treatment of neonatal jaundice , 2001, Acta paediatrica.

[4]  M. J. Maisels,et al.  Does hyperbilirubinemia damage the brain of healthy full-term infants? , 1990, Clinics in perinatology.

[5]  A. Brown Loss of concern about jaundice and the reemergence of kernicterus in full term infants in the era of managed care , 1996 .

[6]  D. Bishai Hearts and minds and child restraints in airplanes. , 2003, Archives of pediatrics & adolescent medicine.

[7]  Brian D Johnston,et al.  Effects and costs of requiring child-restraint systems for young children traveling on commercial airplanes. , 2003, Archives of pediatrics & adolescent medicine.

[8]  M. Klebanoff,et al.  Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project. , 1993, Pediatrics.

[9]  F. Ebbesen Recurrence of kernicterus in term and near‐term infants in Denmark , 2000, Acta paediatrica.

[10]  J. F. Watchko,et al.  Bilirubin 20 mg/dL = vigintiphobia. , 1983, Pediatrics.

[11]  M. J. Maisels,et al.  CLINICAL ISSUES: INFANCY AND CHILDHOOD Less Aggressive Treatment of Neonatal Jaundice and Reports of Kernicterus: Lessons About Practice Guidelines , 2000 .

[12]  V. Bhutani,et al.  Guidelines for management of the jaundiced term and near-term infant. , 1998, Clinics in perinatology.

[13]  A. Tversky,et al.  Judgment under Uncertainty: Heuristics and Biases , 1974, Science.

[14]  T B Newman,et al.  Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. , 1992, Pediatrics.

[15]  Subcommittee on Hyperbilirubinemia Practice Parameter: Management of Hyperbilirubinemia in the Healthy Term Newborn , 1994, Pediatrics.